These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


734 related items for PubMed ID: 9080123

  • 1. Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model.
    Ju DW, Cao X, Acres B.
    Cancer Gene Ther; 1997; 4(2):139-44. PubMed ID: 9080123
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic effect of vaccinia virus secreting granulocyte-macrophage colony-stimulating factor on pulmonary metastatic melanoma].
    Ju D, Cao X, Ma S.
    Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):165-8. PubMed ID: 9387245
    [Abstract] [Full Text] [Related]

  • 3. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ, Kim JH, Lee YS, Kim J, Suh BS, Kim H, Cho S, Sohn JH, Kim GE, Yun CO.
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [Abstract] [Full Text] [Related]

  • 4. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
    Cao X, Huang X, Ju DW, Zhang W, Hamada H, Wang J.
    Cancer Gene Ther; 2000 Feb; 7(2):177-86. PubMed ID: 10770625
    [Abstract] [Full Text] [Related]

  • 5. Combination of intratumoral injections of vaccinia virus MVA expressing GM-CSF and immunization with DNA vaccine prolongs the survival of mice bearing HPV16 induced tumors with downregulated expression of MHC class I molecules.
    Nemeckova S, Smahel M, Hainz P, Mackova J, Zurkova K, Gabriel P, Indrova M, Kutinova L.
    Neoplasma; 2007 Feb; 54(4):326-33. PubMed ID: 17822323
    [Abstract] [Full Text] [Related]

  • 6. Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells.
    Klimp AH, Regts J, Scherphof GL, de Vries EG, Daemen T.
    Br J Cancer; 1999 Jan; 79(1):89-94. PubMed ID: 10408698
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity.
    Wang L, Qi X, Sun Y, Liang L, Ju D.
    Cancer Gene Ther; 2002 Oct; 9(10):819-24. PubMed ID: 12224022
    [Abstract] [Full Text] [Related]

  • 8. Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage-colony-stimulating-factor-gene-encoded vaccinia virus.
    Ju DW, Cao X, Acres B.
    J Cancer Res Clin Oncol; 1996 Oct; 122(12):716-22. PubMed ID: 8954168
    [Abstract] [Full Text] [Related]

  • 9. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
    Vallera DA, Taylor PA, Aukerman SL, Blazar BR.
    Cancer Res; 1993 Sep 15; 53(18):4273-80. PubMed ID: 8364923
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Construction of recombinant vaccinia virus expressing GM-CSF and its use as tumor vaccine.
    Qin HX, Chatterjee SK.
    Gene Ther; 1996 Jan 15; 3(1):59-66. PubMed ID: 8929912
    [Abstract] [Full Text] [Related]

  • 12. Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.
    Toda M, Martuza RL, Rabkin SD.
    Mol Ther; 2000 Oct 15; 2(4):324-9. PubMed ID: 11020347
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B, Lalani AS, Harding TC, Luan B, Koprivnikar K, Huan Tu G, Prell R, VanRoey MJ, Simmons AD, Jooss K.
    Clin Cancer Res; 2006 Nov 15; 12(22):6808-16. PubMed ID: 17121902
    [Abstract] [Full Text] [Related]

  • 14. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice.
    Cao X, Ju DW, Tao Q, Wang J, Wan T, Wang BM, Zhang W, Hamada H.
    Gene Ther; 1998 Aug 15; 5(8):1130-6. PubMed ID: 10326037
    [Abstract] [Full Text] [Related]

  • 15. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S, Saï P, Bach JM.
    Immunol Lett; 2004 Feb 15; 91(2-3):221-7. PubMed ID: 15019293
    [Abstract] [Full Text] [Related]

  • 16. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF.
    Shi FS, Weber S, Gan J, Rakhmilevich AL, Mahvi DM.
    Cancer Gene Ther; 1999 Feb 15; 6(1):81-8. PubMed ID: 10078967
    [Abstract] [Full Text] [Related]

  • 17. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y, Kono T, Yasumoto R, Kishimoto T, Wang CY, Haas GP, Nishisaka N.
    J Immunother; 2001 Feb 15; 24(3):205-11. PubMed ID: 11394497
    [Abstract] [Full Text] [Related]

  • 18. Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma.
    Mastrangelo MJ, Maguire HC, Eisenlohr LC, Laughlin CE, Monken CE, McCue PA, Kovatich AJ, Lattime EC.
    Cancer Gene Ther; 1999 Feb 15; 6(5):409-22. PubMed ID: 10505851
    [Abstract] [Full Text] [Related]

  • 19. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
    Mach N, Gillessen S, Wilson SB, Sheehan C, Mihm M, Dranoff G.
    Cancer Res; 2000 Jun 15; 60(12):3239-46. PubMed ID: 10866317
    [Abstract] [Full Text] [Related]

  • 20. Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer.
    Day KV, Li D, Liu S, Guo M, O'Malley BW.
    Laryngoscope; 2001 May 15; 111(5):801-6. PubMed ID: 11368071
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.